Status:
RECRUITING
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
Idiopathic Pulmonary Fibrosis Clinical Research Network
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Interstitial Lung Diseases
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group f...
Eligibility Criteria
Inclusion
- Interstitial lung disease
Exclusion
- Does not have Interstitial lung disease
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT00470327
Start Date
September 1 2005
End Date
December 1 2030
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago
Chicago, Illinois, United States, 60637